Blog

Latest news about encapsia

Encapsia joins forces with Endpoint

At encapsia, we are pleased to be working with a like-minded partner in endpoint. With both organizations focused on simplifying the user experience and management of complex trials through technology, it was a natural step to integrate our two state-of-the-art technology systems to drive innovation and generate significant efficiencies in the clinical trial space.

With encapsia, site users no longer need to use a separate IRT system – they do all their work in encapsia. Complex IRT tasks like managing randomization, drug supply and inventory management, and drug dispensation can now be performed in real-time using the single interface and unified database of encapsia. This revolutionary advancement frees the site users from the time and complexity of working with multiple systems, bringing operational freedom with cost savings that carry through to the entire clinical study.

“One of several direct data collection (DDC) options within encapsia®, eSource DDC holds significant promise for the industry as a standalone option, but its major benefit is bringing simplicity to the complex clinical trials ecosystem of technology and services. To that end, over 2-and-a-half years ago, we leveraged the dynamic architecture of encapsia with the hyper-integration approach endpoint uses in a joint effort to tightly connect systems into one continuum of experience for the sites and study managers alike,” says Temitope Keyes, Executive Director at Cmed Technology.

“The encapsia and endpoint teams have demonstrated a deep commitment to partnership, client success, technological innovation, and thought leadership in the industry that drives our mutual ability to deliver a highly harmonized set of systems together successfully. We provide an intuitive and seamless solution for clinical supplies and clinical operations workflows, always in compliance while utilizing dynamic data in near-real-time.”

This partnership is part of the ConnectionPOINT program which has the sole mission to nurture a sustainable, scalable infrastructure amongst a network of strong, vetted partnerships in support of eClinical business and technology, predicated on the principles of creating opportunities, driving innovation, and harmonizing delivery across the trials ecosystem.

As the complexity of clinical trials steadily increases, encapsia and endpoint are dedicated to minimizing the burden on site staff and provide them with an optimal “consumer-like” experience.
Other partners in ConnectionPOINT are TSS, a leading global provider of temperature monitoring technology and services and McCreadie Group, provider of innovative web-based software for pharmacy education and clinical drug research.


Have questions about how we can help you transform your trial? Contact us info@encapsia.com
To read more about ConnectionPOINT, click here.

Encapsia joins forces with Endpoint

Latest articles

It is no secret that there is a digital transformation happening across life sciences and healthcare. This seismic shift is being facilitated by cutting-edge technology that is enabling the interrogation and aggregation of the vast quantities of data that we now have at our fingertips. The adoption of automated processes using technologies like artificial intelligence (AI), which incorporates human intelligence into machines through a set of rules, and machine learning (ML), an application of AI whereby the computer learns automatically through its experiences, is key to collecting and analyzing the vast and varied data that is now available and facilitating a move to a personalized approach to medicine.
As the ways in which clinical trials are conducted and monitored continue to modernize at pace, there is an urgent need for digital transformation in the industry. If sponsors are to realize their goals of running flexible, decentralized trials (DCT), risk-based management (RBM), or adaptive trials while adopting big data, artificial intelligence / machine learning (AI/ML), the emphasis must now be on technology solutions that optimize clinical trial data workflows by bringing the technology to the data.
Innovative technology for clinical trials is now, more than ever, necessary to deliver decentralized trials (DCT) and enable design of hybrid protocols that support trial continuity and patient-centricity. We’ve added new capabilities for encapsia, after we’ve seen increased demand for its use in decentralized trials. Encapsia delivers a complete solution to gather and manage multiple live clinical data sources and apply real-time data management, sophisticated visualizations, analytics, and AI. Encapsia was designed to address the pain around remote collection, integration, and availability of disparate data.